Approvals/TGA/MOMETASONE GPPL ALLERGY RELIEF mometasone furoate 50 mcg/actuation (as monohydrate) suspension nasal spray bottle

Approved

STANDARD

MOMETASONE GPPL ALLERGY RELIEF mometasone furoate 50 mcg/actuation (as monohydrate) suspension nasal spray bottle

Arrotex Pharmaceuticals Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 05539bd253f6f20c
Product Name: MOMETASONE GPPL ALLERGY RELIEF mometasone furoate 50 mcg/actuation (as monohydrate) suspension nasal spray bottle
Artg Id: 300546
Artg Name: MOMETASONE GPPL ALLERGY RELIEF mometasone furoate 50 mcg/actuation (as monohydrate) suspension nasal spray bottle
Sponsor: Arrotex Pharmaceuticals Pty Ltd
Company Detail Path: /organization/arrotex-pharmaceuticals-pty-ltd
Artg Date: 2018-03-08
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

05539bd253f6f20c

Type

Standard